Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy

BACKGROUND: Conflicting results about the association between expression level of excision repair cross-complementation group 1 (ERCC1) and clinical outcome in patients with colorectal cancer (CRC) receiving chemotherapy have been reported. Thus, we searched the available articles and performed the...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Chin Med J (Engl)
Auteurs principaux: Li, Mu-Xing, Bi, Xin-Yu, Zhao, Hong, Huang, Zhen, Han, Yue, Zhao, Dong-Bin, Zhao, Jian-Jun, Cai, Jian-Qiang
Format: Artigo
Langue:Inglês
Publié: Medknow Publications & Media Pvt Ltd 2016
Sujets:
Meta Analysis
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4804441/
https://ncbi.nlm.nih.gov/pubmed/26904994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0366-6999.176993
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires